The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Hepar Stannum 17/20
Hepar Stannum 17/20 · MAMMAL LIVER 17 [hp_X]/1; TIN 20 [hp_X]/1 · Pellet · Oral · Uriel Pharmacy Inc.
NDC 48951-5046-02 · 1350 PELLET in 1 BOTTLE, GLASS · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Hepar Stannum 17/20 (Pellet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Uriel Pharmacy Inc. | MAMMAL LIVER 17 [hp_X]/1; TIN 20 [hp_X]/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Hepar Stannum 17/20 — NDC 48951-5046-02," retrieved September 3, 2026, https://drugdashboards.com/drug/48951504602.
Free to cite with attribution — see how the data is put together.